depression

9511213674_31a3c06cc7_z

Introduction

Clinical, unipolar depression is more than just feeling low for a day or two.

Depression is characterised as episodes of sadness, loss of interest and pleasure, often including feelings of low self-worth. Depression can also include a range of physiological symptoms, such as fatigue, pain, diminished appetite, lack of interest in sex, disturbed sleep, and poor concentration.

The World Health Organisation estimates that, globally, as many as 350 million people are affected at any given time, with one person in 20 reporting an episode of depression in a 12 month period (in a global sample of 17 countries). They describe depression as the leading cause of disability worldwide.

What we know already

We know that, despite the considerable global burden of depression, not everybody receives treatment, with figures ranging from 50% to 10% in less developed countries.

Evidence suggests that combined psychological and pharmacological treatments seem to work well. Broadly, we know that psychotherapies work in many cases – but not every time. We know that neurochemical factors, such as serotonergic dysfunction, play an important role in depression, which goes a long way in explaining the efficacy of SSRI treatments.

We also know that depression has a nasty habit of recurrence, and some psychological interventions, such as Mindfulness-Based Cognitive Therapy (MBCT) is recommended particularly for people who have experienced multiple episodes of depression, but not are currently severely depressed.

We know that people living with chronic physical illness are more likely to experience depression, and this combination is linked with poorer clinical outcomes.

Importantly though, we know that people with depression can still enjoy themselves, and a common misconception in depression is that people feel totally awful all of the time.

Areas of uncertainty

There is much still to determine. For example, we know that depression is hereditable, however the extent of heredity versus environmental influences are unclear.

We are also unsure as to the precise mechanisms that determine those who respond best to treatments, be they psychopharmacological, or psychological, or both.

What’s in the pipeline?

Despite advances in our understanding of depression, and how it is treated, it remains a highly recurrent difficulty, with many people not achieving complete remission between episodes.

Preventative interventions, either physiological, or psychological, may improve people’s resilience to depression, particularly those identified as being highly prone.

References

Cuijpers, P. (2015). Psychotherapies for adult depression: recent developments. Current Opinion in Psychiatry, 28, 24-29. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK [PDF]

World Health Organisation (2015).Factsheet 369: Depression [Link]

Photo Credits

Sascha Kohlmann CC BY 2.0

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Nov 2015
Review due: Sep 2016

Our depression Blogs

Adverse effects of psychotherapy for depression: new meta-analysis looks at deterioration rates

riccardo-mion-584741-unsplash

Edel Mc Glanaghy reacquaints us with the negative effects of psychotherapies for adult depression, through an impressive new meta-analysis of trials that measure deterioration rates in patients receiving psychotherapy compared with controls.

[read the full story...]

Universal resilience: could it be the answer?

ankush-minda-549369-unsplash

Lucinda Powell summarises a systematic review of universal resilience-focused interventions targeting child and adolescent mental health in the school setting.

[read the full story...]

Poorer cardiovascular screening, diagnosis and management if you have a mental illness

nick-fewings-532590-unsplash

Joanne Wallace summarises a systematic review that highlights disparities in the management of cardiovascular risk factors in people with mental illness.

[read the full story...]

Brutalised child soldiers and traumatic distress

33164568732_7d25b0d71c_k

Our blog today explores a new study in the British Journal of Psychiatry of post-traumatic stress disorder among former Yazidi child soldiers in northern Iraq.

[read the full story...]

Mental health diagnosis: views and experiences of service users and clinicians

ahmed-zayan-586246-unsplash

Vanessa Pinfold and Jennie Parker from the McPin Foundation explore a recent systematic review of service user, clinician, and carer perspectives on mental health diagnosis.

[read the full story...]

Moderated online social therapy: relapse prevention for youth depression

annie-spratt-385366-unsplash

Sarah Knowles looks at a next-generation social media-based relapse prevention intervention for youth depression, explored in an Australian qualitative study looking at social networking, safety and clinical benefit.

[read the full story...]

Should we screen new Dads for depression? #DadsMHday

nick-stephenson-436009-unsplash

André Tomlin shares his own experiences of being diagnosed with postnatal depression and wonders how we can improve screening for other fathers at risk during the perinatal period.

[read the full story...]

Persistent and severe postnatal depression predicts adverse outcomes in children

j-w-675134-unsplash

Sophie Graham and Jennifer Burgess explore the associations between persistent and severe postnatal depression in mothers and mental health and educational outcomes in their offspring.

[read the full story...]

The genetics of depression (and anxiety!)

kristina-tripkovic-649227-unsplash

Thalia Eley shares her thoughts on a recent Nature genome-wide association study of depression phenotypes in the UK Biobank, which uses different definitions of depression to provide more tractable targets for future genetic studies.

[read the full story...]

Resilience to depression: neural markers in adolescent at-risk females

jordi-zamora-179529-unsplash

Matthew Broome appraises a recent cohort study that looks at neural markers of resilience in young women at familial risk for major depressive disorder.

[read the full story...]